1.
Khanban H, Fattahi E, Talkhabi M. In vivo administration of G9a inhibitor A366 decreases osteogenic potential of bone marrow-derived mesenchymal stem cells. EXCLI J. [Internet]. 2019 Jun. 3 [cited 2024 Jul. 19];18:300-9. Available from: https://www.excli.de/index.php/excli/article/view/1070